284 related articles for article (PubMed ID: 33102223)
1. FSRT vs. SRS in Brain Metastases-Differences in Local Control and Radiation Necrosis-A Volumetric Study.
Putz F; Weissmann T; Oft D; Schmidt MA; Roesch J; Siavooshhaghighi H; Filimonova I; Schmitter C; Mengling V; Bert C; Frey B; Lettmaier S; Distel LV; Semrau S; Fietkau R
Front Oncol; 2020; 10():559193. PubMed ID: 33102223
[No Abstract] [Full Text] [Related]
2. Radiation Necrosis Following Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy with High Biologically Effective Doses for Large Brain Metastases.
Johannwerner L; Werner EM; Blanck O; Janssen S; Cremers F; Yu NY; Rades D
Biology (Basel); 2023 Apr; 12(5):. PubMed ID: 37237469
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns.
El Shafie RA; Dresel T; Weber D; Schmitt D; Lang K; König L; Höne S; Forster T; von Nettelbladt B; Eichkorn T; Adeberg S; Debus J; Rieken S; Bernhardt D
Front Oncol; 2020; 10():693. PubMed ID: 32477942
[No Abstract] [Full Text] [Related]
4. Volumetric Regression in Brain Metastases After Stereotactic Radiotherapy: Time Course, Predictors, and Significance.
Oft D; Schmidt MA; Weissmann T; Roesch J; Mengling V; Masitho S; Bert C; Lettmaier S; Frey B; Distel LV; Fietkau R; Putz F
Front Oncol; 2020; 10():590980. PubMed ID: 33489888
[TBL] [Abstract][Full Text] [Related]
5. Salvage Surgical Resection after Linac-Based Stereotactic Radiosurgery for Newly Diagnosed Brain Metastasis.
Matsuda R; Morimoto T; Tamamoto T; Inooka N; Ochi T; Miyasaka T; Hontsu S; Yamaki K; Miura S; Takeshima Y; Tamura K; Yamada S; Nishimura F; Nakagawa I; Motoyama Y; Park YS; Hasegawa M; Nakase H
Curr Oncol; 2021 Dec; 28(6):5255-5265. PubMed ID: 34940078
[TBL] [Abstract][Full Text] [Related]
6. Single-dose versus fractionated stereotactic radiotherapy for brain metastases.
Kim YJ; Cho KH; Kim JY; Lim YK; Min HS; Lee SH; Kim HJ; Gwak HS; Yoo H; Lee SH
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):483-9. PubMed ID: 20800386
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.
Persson O; Bartek J; Shalom NB; Wangerid T; Jakola AS; Förander P
Acta Neurochir (Wien); 2017 Jun; 159(6):1013-1021. PubMed ID: 28409393
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases.
Hirata M; Yasui K; Oota N; Ogawa H; Onoe T; Maki S; Ito Y; Hayashi K; Asakura H; Murayama S; Mitsuya K; Deguchi S; Nakamura K; Hayashi N; Nishimura T; Harada H
Radiat Oncol; 2022 Dec; 17(1):213. PubMed ID: 36578021
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiosurgery versus stereotactic radiotherapy in the management of intracranial meningiomas: a systematic review and meta-analysis.
Fatima N; Meola A; Pollom EL; Soltys SG; Chang SD
Neurosurg Focus; 2019 Jun; 46(6):E2. PubMed ID: 31153149
[TBL] [Abstract][Full Text] [Related]
10. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Hypofractionated Stereotactic Radiotherapy for Small and Moderate-Sized Brain Metastases: A Single-Institution Analysis.
Yan M; Zalay O; Kennedy T; Owen TE; Purzner J; Taslimi S; Purzner T; Alkins R; Moideen N; Fung AS; Moraes FY
Front Oncol; 2022; 12():869572. PubMed ID: 35444935
[TBL] [Abstract][Full Text] [Related]
12. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
Loo M; Pin Y; Thierry A; Clavier JB
Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
[TBL] [Abstract][Full Text] [Related]
13. Comparing pre-operative versus post-operative single and multi-fraction stereotactic radiotherapy for patients with resectable brain metastases.
Perlow HK; Ho C; Matsui JK; Prasad RN; Klamer BG; Wang J; Damante M; Upadhyay R; Thomas E; Blakaj DM; Beyer S; Lonser R; Hardesty D; Raval RR; Prabhu R; Elder JB; Palmer JD
Clin Transl Radiat Oncol; 2023 Jan; 38():117-122. PubMed ID: 36420099
[TBL] [Abstract][Full Text] [Related]
14. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas.
Combs SE; Welzel T; Schulz-Ertner D; Huber PE; Debus J
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):193-200. PubMed ID: 19604653
[TBL] [Abstract][Full Text] [Related]
15. Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
Jhaveri J; Chowdhary M; Zhang X; Press RH; Switchenko JM; Ferris MJ; Morgan TM; Roper J; Dhabaan A; Elder E; Eaton BR; Olson JJ; Curran WJ; Shu HG; Crocker IR; Patel KR
J Neurosurg; 2018 Apr; 130(3):797-803. PubMed ID: 29676690
[TBL] [Abstract][Full Text] [Related]
16. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.
Cho KH; Hall WA; Gerbi BJ; Higgins PD; McGuire WA; Clark HB
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1133-41. PubMed ID: 10613305
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO).
Rogers S; Baumert B; Blanck O; Böhmer D; Boström J; Engenhart-Cabillic R; Ermis E; Exner S; Guckenberger M; Habermehl D; Hemmatazad H; Henke G; Lohaus F; Lux S; Mai S; Minasch D; Rezazadeh A; Steffal C; Temming S; Wittig A; Zweifel C; Riesterer O; Combs SE
Strahlenther Onkol; 2022 Oct; 198(10):919-925. PubMed ID: 36006436
[TBL] [Abstract][Full Text] [Related]
18. SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases.
Crouzen JA; Petoukhova AL; Broekman MLD; Fiocco M; Fisscher UJ; Franssen JH; Gadellaa-van Hooijdonk CGM; Kerkhof M; Kiderlen M; Mast ME; van Rij CM; Nandoe Tewarie R; van de Sande MAE; van der Toorn PPG; Vlasman R; Vos MJ; van der Voort van Zyp NCMG; Wiggenraad RGJ; Wiltink LM; Zindler JD
BMC Cancer; 2023 Mar; 23(1):273. PubMed ID: 36964529
[TBL] [Abstract][Full Text] [Related]
19. Outcomes and the Role of Primary Histology Following LINAC-based Stereotactic Radiation for Sarcoma Brain Metastases.
Sim AJ; Ahmed KA; Keller A; Figura NB; Oliver DE; Sarangkasiri S; Robinson TJ; Johnstone PAS; Yu HM; Naghavi AO
Am J Clin Oncol; 2020 May; 43(5):356-361. PubMed ID: 32217854
[TBL] [Abstract][Full Text] [Related]
20. Effects of two different radiotherapies for craniopharyngiomas using stereotactic radiosurgery/ stereotactic radiotherapy or fractionated stereotactic radiotherapy.
Kamogawa M; Shuto T; Matsunaga S
Surg Neurol Int; 2022; 13():563. PubMed ID: 36600746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
